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Introduction
The hallmark of chronic wounds, such as diabetic lower extremity ulcers, is characterized by a dampened immunologic as well as angiogenic response 1 .
The idea that stem cell applications can improve wound healing is heralded by the efficacy of topical granulocyte/macrophage colony stimulating factor, a growth stimulant for bone marrow derived progenitor cells, in improving wound closure 2, 3 . Clinically, we have also observed that patients with leukemia whose bone marrow is replaced with non-functioning cells have markedly impaired wound healing. Studies of human endothelial progenitor cells in diabetes also demonstrate a decrease in number as well as function 4, 5 . Together, this suggests that chronic wound states that are associated with diabetes may cause an impairment in stem cell function and subsequently, wound healing.
Recently, uses of bone marrow derived stem cells as well as peripheral blood derived endothelial progenitor cells have both been shown to accelerate healing in diabetic mice 6, 7 . Most bone marrow derived cells, however, suffer from poor long-term engraftment. This is not the case in a side population (SP) 8, 9 . This population of bone marrow derived cells has been shown to exhibit true stem cell characteristics. Long term reconstitution of all hematopoietic lineages has been demonstrated 8 . Their pluripotency have been demonstrated in their ability to regenerate myocardium after ischemia/reperfusion injury as well as to reverse dysfunctional skeletal muscle in mice deficient in the mdx dystrophin gene 10, 11 .
Here, we study the effect of this SP cell population on wound closure in an impaired healing model of excisional wounds in genetically diabetic mice.
Materials and Methods

Animals
Male C57/Bl6 wild type mice and lep/r db/db homozygous diabetic mice were purchased from Jackson Labs (Bar Harbor, ME) and used for all experiments. 
Stem cell preparation
Bone marrow specimens extracted from the tibias and femurs of C57BL/6J mice 6 to 12 weeks of age were suspended at 10 
Procedure
Mice, aged 6-8 weeks, were anesthetized with intra-peritoneal pentobarbital (60mg/kg). On the morning prior to surgery, hair was removed by shaving followed by the application of calcium hydroxide based depilatory cream (Sally Hansen, Framingdale, NY). Normal saline was used to clean their backs and the mice were allowed to recover.
The wound was created with sharp excision of a 1.0cm x 1.0cm full thickness area of skin through the panniculus carnosus muscle on the dorsum of the mice under sterile conditions. The wound was covered using a pre-cut piece of Opsite® (Smith and Nephew, Largo, Fl) following benzoine (PDI, Orangeburg, NY) application to increase adhesiveness. 0.2cc of topical MP, or SP containing 8000 cells or saline control were injected on post-operative day 1 through the Opsite® using a 30-gauge needle (n=12 for each group). A digital picture of the wound was taken every 2-3 days for a period of 3 weeks until greater than 90% wound closure. All the wounds were harvested after complete wound closure for histological analysis.
Pathological processing
Wounds were harvested on post-operative day 7 during mid healing and also on post-operative day 25 after complete healing. Tissue was fixed in 10% formalin and embedded in paraffin. Hematoxylin and Eosin stained sections were used to determine quality of wound healing as determined by the amount of granulation tissue and the quality of the epithelium.
Statistical Analysis
Digital photograph was taken twice weekly. Wound area was determined using computer planimetry (Scion Corporation). Wound healing rates were expressed as means +/-standard error in the text and figures. Group comparisons were made using analysis of variance with the Bonferroni correction for multiple comparisons applied. In all cases, p<0.05 is defined as statistical significance.
Results
SP cells have significant effect on wound closure in diabetic mice.
Topical SP treated animals have the most pronounced effect on wound closure with statistically significant improvement in wound healing seen on POD #7, 12 and 15 (p < 0.05, Figure 1A ). The earliest difference is seen on POD #7 when SP cell treated animals are 35% ± 7.2% closed while MP treated animals (16% ± 4.9%) and saline treated animals (14% ± 6.7%) are still poorly healed, p<0.05 
SP treated wounds show improved epithelialization
Histological examination of healing wounds taken on POD#7 reveal enhanced epithelialization in the SP-treated wounds. Figure 3A and 3B shows the transition zone between normal and healing skin from SP and MP treated animals respectively. While the SP-treated wound shows a contiguous epithelial layer, the MP-treated wound shows good granulation tissue formation but an incomplete epithelialization.
When wounds are examined at the end of healing, there are no discernable differences in their gross or histological appearances. Therefore, while the application of SP cells is shown to hasten wound closure rate, it does not result in a qualitatively inferior wound.
Discussion
While it has not yet been conclusively shown that adult stem cells exhibit plasticity across lineages, there is increasing evidence that different stem cell populations play important roles in the healing. Indeed, it has been suggested that they are involved in the healing and regeneration of diverse nonhematological tissues such as the heart, liver, bile ducts and skeletal muscle [12] [13] [14] .
In the study reported here, we found that a population bone marrow derived hematopoietic stem cells has the capacity to improve regeneration of diabetic wounds. Just as importantly, we found that the "main population" (MP), which contains the majority (99%) of bone marrow stem cells, had no effect on wound healing.
Current evidence suggests that chronic wound states including those associated with radiation and diabetes are related to a deficiency of functional stem cells for wound healing 4, 5 . Indeed, the introduction of normal wild type stem cells either locally or systemically was effective in improving wound closure in genetically diabetic mice. On the contrary, the application of these stem cells to wild type animals that already have a normal complement of functional stem cells showed no statistically significant improvement in healing.
While the efficacy of SP cells in wound healing is quite dramatic, our understanding of their mechanism of action is still rudimentary. One mechanism is that they act through the elaboration of cytokines. Indeed, bone marrow has long been known to provide mature inflammatory cells which orchestrate a cascade of events during wound healing that are mediated through cytokines such as platelet derived growth factor, transforming growth factor-beta and vascular endothelial growth factor 15 . This study is important not only in suggesting a novel modality for the treatment of chronic wounds but also in demonstrating the potential for plasticity of these stem cells in a non-hematopoietic tissue. 
